RESUMEN
Duffy antigen receptor for chemokines (DARC) binds to a number of pro-inflammatory chemokines, and since chemokines are known to regulate trafficking of osteoclast (OC) precursors, we predicted that DARC would regulate OC recruitment to sites of inflammation by modulating chemokine activity. To test this hypothesis, we evaluated the mRNA expression of Darc and the chemokines known to bind to DARC, in endothelial cells treated with bacterial lipopolysaccharide (LPS). The mRNA expression of Mcp-1, Rantes, Darc and Ccr5 was significantly increased in endothelial cells in response to LPS treatment. Blocking the function of DARC with neutralizing antibody partially abrogated the effect of LPS on the mRNA expression of Mcp-1 and Rantes. In vivo, mice with targeted disruption of Darc gene (Darc-KO) and control wild-type (WT) mice were used to assess the role of DARC in response to single LPS application on the top of parietal bones. Five hours post-LPS injection, local expression of Cd14 mRNA (a marker of inflammatory monocytes) was significantly increased in both lines of mice. However, the magnitude of increase was greater in WT mice compared with Darc-KO mice suggesting a role for DARC in mediating the recruitment of monocytes in response to LPS. Histological staining for tartrate-resistant acid phosphatase (TRAP) in calvaria sections taken from the injection sites revealed a significant reduction in TRAP-labeled surface per bone surface in response to LPS in Darc-KO mice compared with WT mice. Based on these findings, we concluded that DARC regulates recruitment of OC precursors at the inflammation site, probably through regulation of chemokines transcytosis across endothelial cell barrier.
Asunto(s)
Quimiocinas , Quimiotaxis , Sistema del Grupo Sanguíneo Duffy , Osteoclastos , Receptores de Superficie Celular , Animales , Ratones , Proteínas Bacterianas/metabolismo , Quimiocinas/metabolismo , Quimiotaxis/fisiología , Sistema del Grupo Sanguíneo Duffy/metabolismo , Inflamación/metabolismo , Inflamación/patología , Lipopolisacáridos/metabolismo , Ratones Endogámicos C57BL , Ratones Noqueados , Osteoclastos/metabolismo , Receptores de Superficie Celular/metabolismo , Células Madre/metabolismoRESUMEN
The use of nanotechnology in the field of acidizing, particularly in fracturing fluids, has garnered significant attention over the past decade. Viscoelastic surfactants (VESs) are utilized as one of the most effective fracturing fluids, possessing both elasticity and viscosity properties. These fluids are crucial additives in acidizing packages, enhancing their performance. However, various factors, such as salinity, temperature, pressure, and concentration, can sometimes weaken the efficacy of these fluids. To address this, the integration of nanoparticles has been explored to improve fluid retention in reservoirs and enhance the efficiency. This study focuses on investigating the impact of the main metallic-type nanoparticles on the rheological behavior of VES fluids. Iron oxide, magnesium oxide, and zinc oxide nanoparticles were utilized, and the microscopic-scale rheological behavior of the fluids was thoroughly evaluated. The highest performance for enhancing fluid gelation, stability, and rheological characteristics of VES fluids was found for Fe2O3 nanoparticles at an optimum concentration of 500 ppm. At this concentration and shear rate of 100 s-1, the viscosity of the fluid reached 169.61 cP. For iron oxide nanoparticles at a concentration of 500 ppm, by increasing the temperature from 25 to 85 °C, the gelation state of the fluid increased from 7 h and 50 min to 17 h and 45 min. This improvement is attributed to their high surface area and the increased density of entanglement points within the micelles, leading to a more interconnected structure with enhanced viscoelastic properties. Furthermore, iron oxide nanoparticles significantly enhance gelation by physically connecting the micelles, thereby improving stability and structure. The absorption of surfactant molecules by the nanoparticles additionally contributes to micelle reconstruction and shape alteration. The presence of iron oxide nanoparticles helps maintain the gel structure even at elevated temperatures, preventing rapid viscosity decrease. Our findings may provide new insights for development of high-performance, economical, and environment-friendly fracturing fluids used in well stimulation operations.
RESUMEN
In our study, blood concentrations of lead (Pb), arsenic (As), and cadmium (Cd) and urine concentrations of thallium (Tl) were measured together with related symptoms of heavy metal poisoning in cigarette smoking volunteers diagnosed with schizophrenia, in cigarette smokers not diagnosed with schizophrenia, and in the control group of non-smokers and not diagnosed with schizophrenia volunteers. Our study was performed on 171 volunteers divided into the following subgroups: patients diagnosed with schizophrenia with at least 1 year of continuous cigarette smoking experience (56 participants), cigarette smokers not diagnosed with schizophrenia with at least one year of continuous smoking experience (58), and control group (not diagnosed with schizophrenia and non-smoking volunteers) (57). Smoking durations of cigarette smokers diagnosed with schizophrenia and cigarette smokers not diagnosed with schizophrenia are not similar (p = 0.431). Blood Pb, As, and Cd concentrations and urine Tl concentrations were the highest in the subgroup of cigarette smokers not diagnosed with schizophrenia, followed by the subgroup of cigarette smokers diagnosed with schizophrenia, and the control group. Only blood Pb concentrations were significantly higher (probability value p < 0.05) in the group of cigarette smokers not diagnosed with schizophrenia (5.16 µg/dL), comparing to the group of cigarette smokers diagnosed with schizophrenia (3.83 µg/dL) and to the control group (3.43 µg/dL). Blood Cd and As concentrations and urine Tl concentrations were significantly higher (p < 0.05) in cigarette smokers not diagnosed with schizophrenia than in the control group. The results revealed a statistically significant positive correlation (p < 0.001) in the cigarette smokers in the schizophrenia diagnosed group between blood Pb, blood As, and urine Tl concentrations and the duration of cigarette smoking.
Asunto(s)
Cadmio , Fumar Cigarrillos , Plomo , Esquizofrenia , Humanos , Esquizofrenia/sangre , Esquizofrenia/etiología , Masculino , Adulto , Femenino , Fumar Cigarrillos/efectos adversos , Fumar Cigarrillos/sangre , Plomo/sangre , Plomo/orina , Cadmio/sangre , Cadmio/orina , Persona de Mediana Edad , Metales Pesados/sangre , Metales Pesados/orina , Arsénico/sangre , Arsénico/orina , Talio/sangre , Talio/orina , Estudios de Casos y ControlesRESUMEN
Background: Smoking is clearly associated with metabolic profiles/abnormalities, psychological dysfunction, and symptoms of nicotine dependence. Nano-Curcumin (Nano-CUR) is a medicinal herb with antianxiety, antioxidant antidepressant-like effects, and anti-inflammatory properties. This RCT aimed to determine the therapeutic effects of Nano-CUR in smokers on clinical symptoms and metabolic parameters. Methods: This trial was conducted on 70 participants with cigarette smoking. Smokers in two arms received soft gel capsules Nano-CUR 80 mg/daily for 3 months (n = 35) and placebo (n = 35), respectively. Primary outcomes (Nicotine dependence syndrome scale, depression, and anxiety beck score), and secondary outcomes (glycemic, lipid, stress oxidative, and inflammation profiles) were analyzed before and 3-months after the intervention in smokers. Results: Nano-CUR supplementation significantly decreased nitric oxide, malondialdehyde, and C-reactive protein levels (P < 0.05), compared to the control. Furthermore, no significant effect change was shown in nicotine dependence syndrome, depression, anxiety, and other metabolic parameters (p > 0.05). Conclusion: Nano-CUR intake may have favorable effects on C-reactive protein, malondialdehyde, and nitric oxide in subjects with cigarette smoking. More RCT are required to evaluate the effectiveness of Nano-CUR supplementations in smokers in order to reject or support these conclude.
RESUMEN
Drug abuse has a high prevalence worldwide and causes many health-related disorders. There are limited human exposure studies on establishing lead exposure levels and their propensity for drug addiction. In the present study, blood samples were tested for lead (Pb) concentrations in illicit drug users together with the related symptoms in comparison with control group of non-drug users. The study was performed on 250 volunteers divided equally in four drug groups, namely, opioids, hashish, methadone, and methamphetamine, and one control group of non-drug users. Participants were recruited from drug addiction clinics and camps in Kashan city, Iran, who were using drugs continuously for more than 1 year. Control group was recruited from companions of the patients with no drug use history. In the investigated groups of drug users, the highest blood-lead level (BLL) concentrations were observed in the opioid group (mean 37.57 µg/dL) with almost 3.7 times higher than in the control group (mean 3.39 µg/dL). In the methamphetamine group, type of occupation had the significant association with BLL concentrations. The positive correlation was revealed in the opioid and methadone groups for BLL concentrations and the duration of drug usage. In the opioid group, the highest BLL concentrations were observed among users who used both methods of drug use: smoking and eating. Also, several behavioral and life-style factors were identified which influence the blood-lead concentration in the drug users. The results of our study revealed that the BLL concentrations in investigated drug users' groups were significantly higher than in the control group (P < 0.001). That can be related with the Pb contents in illicitly used drugs. Apart other adverse health effects, long-term illicit drug use might cause to lead poisoning.
Asunto(s)
Drogas Ilícitas , Metanfetamina , Trastornos Relacionados con Sustancias , Humanos , Plomo , Analgésicos Opioides , Irán , Trastornos Relacionados con Sustancias/epidemiología , MetadonaRESUMEN
BACKGROUND: Clove oil is known for its medicinal properties. The mechanism of anti-cancer properties of Syzygium aromaticum were investigated by mathematical modelling on the genome scale with metabolomics using 1H Nuclear Magnetic Resonance spectroscopy on Raji cells. OBJECTIVES: An integrative analysis correlated the metabolites identified by 1HNMR and genes with the detected pathways. MATERIALS AND METHODS: Raji cells treated with clove oil were collected and sent for 1HNMR spectroscopy and the spectra analyzed by MATLAB and Human Metabolome Database for metabolite identification. Pathway and topology analysis was implemented using the genes and metabolites in the integrative analysis of Metaboanalyst software. RESULTS: 50% inhibitory concentration of clove oil was 50 µg/ml and the model anticipated 74 genes with differentiating metabolites being some amino acids, cholesterol and fucose. CONCLUSION: The integrative study predicted that the anti cancer mechanism of clove oil involves novel enzymes, as likely drug targets, 24-dehydrocholesterol reductase and 7-dehydrocholesterol reductase in cholesterol biosynthesis, dehydrofolate reductase in one carbon metabolism and serine palmitoyl-transferase long chain in sphingolipid biosynthesis.